Mary E. West, MS

Mary E. West, MS has over 20 years of experience in the pharmaceutical and biotechnology industries. Mary E. began their career in 1997 as a Research Associate/Clinical Research Associate at Pfizer (formerly Parke-Davis Pharmaceuticals). Mary E. then moved to Millennium Pharmaceuticals in 2001 as a Clinical Research Manager I, II. In 2005, they became a Clinical Program Manager at Acambis (Acquired by Sanofi-Pasteur). Mary then moved to Momenta Pharmaceuticals in 2007 as a Clinical Project Manager. In 2009, they became a Sr. Manager, Clinical Operations at Paratek Pharmaceuticals, Inc. In 2013, they took a position as an Associate Director, Clinical Operations at Alnylam Pharmaceuticals, where they were the Global Clinical Operations lead for patisiran (ONPATTRO). In 2018, they became a Sr. Director and Head of Clinical Operations at BlueRock Therapeutics. In 2019, they moved to Skyhawk Therapeutics as a Sr. Director, Clinical Operations. Finally, in 2020, they became a Vice President, Clinical Operations at Talaris Therapeutics, and is currently a Vice President, Clinical Operations at Tectonic Therapeutics, Inc.

Mary E. West, MS completed their Master's degree in Project Management at Boston University in 2010 and their Bachelor's degree in Dietetics/Dietitian at Michigan State University in 1997.